ES2171104B1 - Procedimiento de identificacion de la metaloproteasa humana matrilisina-2. - Google Patents

Procedimiento de identificacion de la metaloproteasa humana matrilisina-2.

Info

Publication number
ES2171104B1
ES2171104B1 ES009902653A ES9902653A ES2171104B1 ES 2171104 B1 ES2171104 B1 ES 2171104B1 ES 009902653 A ES009902653 A ES 009902653A ES 9902653 A ES9902653 A ES 9902653A ES 2171104 B1 ES2171104 B1 ES 2171104B1
Authority
ES
Spain
Prior art keywords
human
sequence
matrilisina
metaloprotease
identification procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES009902653A
Other languages
English (en)
Other versions
ES2171104A1 (es
Inventor
Campos Jose Antonio Uria
Otin Carlos Lopez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad de Oviedo
Original Assignee
Universidad de Oviedo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad de Oviedo filed Critical Universidad de Oviedo
Priority to ES009902653A priority Critical patent/ES2171104B1/es
Publication of ES2171104A1 publication Critical patent/ES2171104A1/es
Application granted granted Critical
Publication of ES2171104B1 publication Critical patent/ES2171104B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

Procedimiento de identificación de la metaloproteasa humana matrilisina-2. La invención consiste en identificar fragmentos de genes humanos similares a secuencias de genes de metaloproteasas, amplificarlos mediante PCR de RNA de tejidos humanos, extender la secuencia de los fragmentos obtenidos hacia los extremos 5'' y 3'' y determinar la secuencia de clones de cDNA generados. La secuencia identificada es SEQ ID NO: 1 y se ha denominado matrilisina-2. La aplicación de dicha secuencia está relacionada fundamentalmente con la diagnosis y el tratamiento de los procesos tisulares.
ES009902653A 1999-11-29 1999-11-29 Procedimiento de identificacion de la metaloproteasa humana matrilisina-2. Expired - Fee Related ES2171104B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES009902653A ES2171104B1 (es) 1999-11-29 1999-11-29 Procedimiento de identificacion de la metaloproteasa humana matrilisina-2.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009902653A ES2171104B1 (es) 1999-11-29 1999-11-29 Procedimiento de identificacion de la metaloproteasa humana matrilisina-2.

Publications (2)

Publication Number Publication Date
ES2171104A1 ES2171104A1 (es) 2002-08-16
ES2171104B1 true ES2171104B1 (es) 2003-12-16

Family

ID=8310791

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009902653A Expired - Fee Related ES2171104B1 (es) 1999-11-29 1999-11-29 Procedimiento de identificacion de la metaloproteasa humana matrilisina-2.

Country Status (1)

Country Link
ES (1) ES2171104B1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6241698A (en) * 1997-01-21 1998-08-07 Human Genome Sciences, Inc. Tace-like and matrilysin-like polypeptides
DE19817948A1 (de) * 1998-04-17 1999-10-21 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Endometrium-Tumor

Also Published As

Publication number Publication date
ES2171104A1 (es) 2002-08-16

Similar Documents

Publication Publication Date Title
ES2306483T5 (es) Prote�?na inhibidora de la ruta de señalización de wnt.
BR0013966A (pt) Compostos espiroeterocìclicos úteis como inibidores reversìveis de proteases de cisteìna
PT1038022E (pt) Avaliacao de doencas relacionadas com o virus papiloma humano
WO1999047669A3 (de) Menschliche nukleinsäuresequenzen aus brusttumorgewebe
RU2004116308A (ru) Морфогенные белки кости (вмр), рецепторы вмр и связывающие вмр белки и их применение для диагностики и лечения глаукомы
DK1378571T3 (da) 5' ESTs for sekreterede proteiner udtrykt i forskellige væv
DK1000149T3 (da) 5'-EST'ere til udskilte proteiner identificeret fra hjernevæv
DE69834727D1 (de) 5' ests für sekretierte proteine die in verschiedenen geweben expremiert werden
ATE374618T1 (de) Verwendung von rekombinanten menschlichen uteroglobin zur behandlung von fibrotischen krankheitszuständen
DE50010519D1 (de) Pharmazeutische Zusammensetzungen zur Therapie der Herzinsuffizienz
WO2004076614A3 (de) Humane nukleinsäuresequenzen aus prostatakarzinomen
ES2171104B1 (es) Procedimiento de identificacion de la metaloproteasa humana matrilisina-2.
AU2002333885A1 (en) Single nucleotide polymorphisms predicting cardiovascular disease
DE60123109D1 (de) Mit schizophrenie in zusammenhang stehendes gen, das für ein potential-abhängiges ionkanal kodiert
WO2005039495A3 (en) Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies
NO20052525L (no) Spleisevariant av humant hypofyseveksthormon
WO1999054448A3 (de) Menschliche nukleinsäurefragmente, deren expression in uterusmyomgewebeerhoeht ist
WO2000058464A3 (en) Rab genes and their uses
ATE420210T1 (de) Diagnose des brustkrebsrisikos
JP2004503214A5 (es)
WO2000050601A3 (en) Nucleic acid and amino acid sequences of hemoglobin-response genes in candida albicans and the use of reagents derived from these sequences in the diagnosis of disseminated candida albicans infection
AU2001261674A1 (en) Treatment methods using 17906 and uses therefor
WO2004056863A8 (en) Splice variant of human placental growth hormone
WO2002077234A3 (en) Compositions and methods relating to colon specific genes and proteins
WO2001040493A3 (en) Schizophrenia associated gene, proteins and biallelic markers

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20020816

Kind code of ref document: A1

Effective date: 20020816

FG2A Definitive protection

Ref document number: 2171104B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20200306